No definite cause has been determined. The peak incidence of lymphocytic colitis is in persons over age 50; the disease affects women and men equally. Some reports have implicated long-term usage of
NSAIDs,
proton pump inhibitors, and
selective serotonin reuptake inhibitors, and other drugs. Associations with other
autoimmune disorders suggests that overactive immune responses occur.[3]
Diagnosis
The
colonoscopy is normal but histology of the mucosal biopsy reveals an accumulation of
lymphocytes in the colonic epithelium and connective tissue (
lamina propria).
Collagenous colitis shares this feature but additionally shows a distinctive thickening of the subepithelial collagen table.[1][2]
Treatment
Budesonide, in colonic release preparations, has been shown in randomized controlled trials to be effective in treating this disorder.[4][5]
Over-the-counter antidiarrheal drugs may be effective for some people with lymphocytic colitis. Anti-inflammatory drugs, such as
salicylates,
mesalazine, and systemic
corticosteroids may be prescribed for people who do not respond to other drug treatment. The long-term prognosis for this disease is good with a proportion of people suffering relapses which respond to treatment.[1]
History
Lymphocytic colitis was first described in 1989.[6]
^Fernández-Bañares F, Salas A, Esteve M, Espinós J, Forné M, Viver J (2003). "Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up". Am J Gastroenterol. 98 (2): 340–7.
doi:
10.1111/j.1572-0241.2003.07225.x.
PMID12591052.
S2CID1983209.
^Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM (1989). "Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis". Hum. Pathol. 20 (1): 18–28.
doi:
10.1016/0046-8177(89)90198-6.
PMID2912870.